UK Parliament approves permanent intragroup derivatives exemption framework

The House of Commons approved the intragroup OTC derivatives regulations on 14 October 2026, completing parliamentary approval after the Lords agreed them on 7 September. Parliament now records that the instrument can be made. This is an implementation milestone: approval itself does not establish the date on which firms can start using the new arrangements.[1]

The Treasury’s policy replaces reliance on country-equivalence decisions with a permanent route for qualifying group transactions. Its commercial rationale is that internal derivatives let businesses consolidate exposures and manage external hedging centrally. Removing repeated uncertainty about temporary relief could make the location and funding of those arrangements easier to plan.[4]

A shorter margin process, with eligibility still attached

The notification period begins the day after receipt of a complete notification. Qualifying exemptions held at commencement carry over where the specified earlier application or notification received approval or no objection.[2]

The present temporary intragroup exemption regime, TIGER, is scheduled to end on 31 December 2026, subject to earlier relevant equivalence decisions. The FCA’s current guidance therefore remains the starting point for a firm establishing its position before the replacement takes effect.[3]

Completeness becomes part of the operating timetable

The FCA’s supporting CP25/30 proposes retaining counterparty identifiers, the group relationship and an explanation of risk management while reducing routine requests for transaction detail and supporting documents. It would also avoid a new notification solely because an already exempt counterparty pair adds another transaction type. These are proposals for the technical process.[5]

A particularly consequential proposal concerns follow-up questions. If the FCA requests additional documentation within the initial 30 days, the notification period would begin when it receives the requested information. A submission date alone would therefore be a weak basis for scheduling the first trade that depends on an exemption.[5]

For a group treasury, that makes the evidence package part of execution planning. The practical file would connect each legal entity to its consolidation treatment, relevant internal controls and the particular exemption being used. A change in the organisation chart or funding arrangements could matter more than the number of derivative tickets processed. Treating every internal trade as equivalent would obscure the entity-level conditions on which the operational benefit depends.

Keep collateral, capital and reporting decisions separate

The Treasury distinguishes the clearing and margin reform from prudential credit valuation adjustment capital treatment. It also leaves the separate intragroup reporting exemption outside this reform. A group should therefore assess collateral relief, capital treatment and reporting through their respective routes.[4]

Consider an illustrative treasury structure: operating companies hedge with a central group entity, which then offsets the consolidated exposure with an external dealer. Relief on qualifying internal contracts can change where liquidity is needed within that structure. The external dealer-facing contract still needs its own treatment. The size of any commercial benefit depends on the contracts, exposures and funding arrangements; the existence of an internal exemption alone cannot determine a cash saving.

The draft links commencement to revocation of Part 5 of the relevant 2019 EU-exit regulations, rather than setting a calendar start date.[2]

The FCA consultation closed on 16 January 2026. Its published next-steps page, checked on 20 October, still refers to a forthcoming policy statement. For implementation planning, the outstanding checkpoints are the made regulations, their commencement and the final supporting FCA rules.[6]

Report an error or submit an update